Pyonephrosis cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pyonephrosis}} | {{Pyonephrosis}} | ||
{{CMG}}; {{AE}} {{HVC}} | |||
==Cost-effectiveness of therapy== | |||
Given the significant morbidity and rapid mortality associated with pyonephrosis, and the low cost of safe and effective antibiotics, current pharmacotherapy in combination with urgent decompression to treat pyonephrosis is relatively cost-effective.<ref name="pmid33671431">{{cite journal| author=Tamburrini S, Lugarà M, Iannuzzi M, Cesaro E, De Simone F, Del Biondo D | display-authors=etal| title=Pyonephrosis Ultrasound and Computed Tomography Features: A Pictorial Review. | journal=Diagnostics (Basel) | year= 2021 | volume= 11 | issue= 2 | pages= | pmid=33671431 | doi=10.3390/diagnostics11020331 | pmc=7921924 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33671431 }} </ref> | Given the significant morbidity and rapid mortality associated with pyonephrosis, and the low cost of safe and effective antibiotics, current pharmacotherapy in combination with urgent decompression to treat pyonephrosis is relatively cost-effective.<ref name="pmid33671431">{{cite journal| author=Tamburrini S, Lugarà M, Iannuzzi M, Cesaro E, De Simone F, Del Biondo D | display-authors=etal| title=Pyonephrosis Ultrasound and Computed Tomography Features: A Pictorial Review. | journal=Diagnostics (Basel) | year= 2021 | volume= 11 | issue= 2 | pages= | pmid=33671431 | doi=10.3390/diagnostics11020331 | pmc=7921924 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33671431 }} </ref> | ||
Latest revision as of 08:31, 17 October 2021
Pyonephrosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pyonephrosis cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Pyonephrosis cost-effectiveness of therapy |
Risk calculators and risk factors for Pyonephrosis cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Harsh Vardhan Chawla, M.B.B.S.[2]
Cost-effectiveness of therapy
Given the significant morbidity and rapid mortality associated with pyonephrosis, and the low cost of safe and effective antibiotics, current pharmacotherapy in combination with urgent decompression to treat pyonephrosis is relatively cost-effective.[1]
References
- ↑ Tamburrini S, Lugarà M, Iannuzzi M, Cesaro E, De Simone F, Del Biondo D; et al. (2021). "Pyonephrosis Ultrasound and Computed Tomography Features: A Pictorial Review". Diagnostics (Basel). 11 (2). doi:10.3390/diagnostics11020331. PMC 7921924 Check
|pmc=
value (help). PMID 33671431 Check|pmid=
value (help).